MICHELLE BARNAS: Open Payments
NPI 1477803989 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 23 payments from 12 companies in 2025. Trend: 2023 $853 · 2024 $808 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $181 |
| Lilly USA, LLC | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $30 |
| Organogenesis Inc. | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Almirall LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: SKYRIZI, BOTOX, TREMFYA, DUPIXENT, EBGLYSS, AFFINITY, OPZELURA, TALTZ.
Industry payments across FL — which companies pay providers there.
